Evidence map›Paper›PMID 24424413›Full record

ArticleeLife2014

T cell immunodominance is dictated by the positively selecting self-peptide.

Wan-Lin Lo, Benjamin D Solomon, David L Donermeyer, Chyi-Song Hsieh, Paul M Allen

Abstract read
In one paragraph

Article in eLife, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wan-Lin LoDepartment of Immunology and Pathology, Washington University School of Medicine, St. Louis, United States.
Benjamin D Solomon
David L Donermeyer
Chyi-Song Hsieh
Paul M Allen

Funding

T Cell Recognition of AntigenR37AI024157 · NIAID · WASHINGTON UNIVERSITY · PI ALLEN, PAUL M · 2002 to 2011
$3.5M
RECOGNITION AND SIGNALING IN POSITIVE SELECTION OF CD4+ T CELLSR01AI024157 · NIAID · WASHINGTON UNIVERSITY · PI ALLEN, PAUL M · 1987 to 2016
$2.5M
NIAID NIH HHS AI-24157NIAID NIH HHS R01 AI024157NIAID NIH HHS R37 AI024157
6 · The paper itself

Abstract

Naive T cell precursor frequency determines the magnitude of immunodominance. While a broad T cell repertoire requires diverse positively selecting self-peptides, how a single positively selecting ligand influences naive T cell precursor frequency remains undefined. We generated a transgenic mouse expressing a naturally occurring self-peptide, gp250, that positively selects an MCC-specific TCR, AND, as the only MHC class II I-E(k) ligand to study the MCC highly organized immunodominance hierarchy. The single gp250/I-E(k) ligand greatly enhanced MCC-tetramer(+) CD4(+) T cells, and skewed MCC-tetramer(+) population toward V11α(+)Vβ3(+), a major TCR pair in MCC-specific immunodominance. The gp250-selected V11α(+)Vβ3(+) CD4(+) T cells had a significantly increased frequency of conserved MCC-preferred CDR3 features. Our studies establish a direct and causal relationship between a selecting self-peptide and the specificity of the selected TCRs. Thus, an immunodominant T cell response can be due to a dominant positively selecting self-peptide. DOI: http://dx.doi.org/10.7554/eLife.01457.001.

Indexed as

AnimalsCD4-Positive T-LymphocytesCell ProliferationCells, CulturedComplementarity Determining RegionsCytochromes cH-2 AntigensHistocompatibility Antigens Class IIImmunodominant EpitopesInsect ProteinsLigandsLymphocyte ActivationMiceMice, KnockoutMice, TransgenicPeptide FragmentsComplementarity Determining RegionsCytochromes cH-2 AntigensHistocompatibility Antigens Class IIImmunodominant EpitopesInsect ProteinsLigandsPeptide FragmentsReceptors, Antigen, T-CellimmunodominanceMCC responsespositive selectionself-peptide

Identifiers

PMID24424413
PMCPMC3885792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.